Labshake search
Citations for Bio X Cell :
1 - 50 of 652 citations for 8 5 6 7 DIHYDRO 2 4 DIPHENYL 5H 1 BENZOPYRAN 8 YL 2 4 PENTADIENYLIDENE 5 6 7 8 TETRAHYDRO 2 4 DIPHENYL 1 BENZOPYRYLIUM TETRAFLUOROBORATE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-2 (8 μg/mL, Bio X Cell), anti–mIL-4 (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-2 (8 μg/mL, Bio X Cell), anti–mIL-4 (8 μg/mL ...
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Immunology 2021Quote: ... plus 2 µg/mL anti-IL-4 antibody (BioXcell, Clone: 11B11); Th17 ...
-
bioRxiv - Immunology 2021Quote: Intraperitoneal injections of αPDL1 (200 μg/injection on days 4, 8, 14, and 18; clone 10F.9G2; BioXcell), and HMGN1 and its-derived peptdies (0.08 μg on days 9 ...
-
bioRxiv - Immunology 2019Quote: ... with 5 μg purified anti-mouse IL-2 antibody (JES6-1, BioXcell) for 30 min at 37°C (molar ratio for IL2:anti-IL-2 is 2:1) ...
-
bioRxiv - Cancer Biology 2024Quote: Antibody administration of anti-VLA-4 (clone PS/2, Bio X Cell #BE0071), anti-4-1BB (clone LOB12.3 ...
-
bioRxiv - Immunology 2021Quote: ... 2 µg/mL anti-IL-4 and anti-IFNγ antibody (BioXcell, Clone: XMG 1.2). 10 µM SB525334 was used to replace TGF-β to inhibit TGF-β signaling if required ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Cancer Biology 2022Quote: ... 6–8-week-old FVBN mice were treated with three doses of CSF1 neutralizing antibody (clone 5A1; BioXCell, Lebanon, NH, USA) (1 mg ...
-
bioRxiv - Cancer Biology 2020Quote: ... intraperitoneal anti-CD-8 (Bio X Cell® BE0004-1 Clone 53-6.72) or control antibody was injected at a dose of 10 mg/kg on days 0 ...
-
bioRxiv - Immunology 2023Quote: ... or 4-1BB (5 µg/ml, clone 3H3, BE0239) all from BioXCell. Unless otherwise stated ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of 10μg/ml rIL-6 (R&D) and neutralizing antibodies to IL-2 (JES6-1A12 BioXcell, 5μg/ml and S4B6-1 BioXcell, 5μg/mL).
-
bioRxiv - Immunology 2020Quote: ... and/or human CD8α (Bioxcell, OKT-8) three days prior to first treatment and concurrently with subsequent treatments.
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Cancer Biology 2024Quote: ... and/or 5 mg/kg anti-CTLA-4 (clone 9H10, cat. BE0131, BioXcell). Antibodies were dissolved in PBS and administered via intraperitoneal injection (4 μl/g ...
-
bioRxiv - Cancer Biology 2023Quote: ... or isotype control antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone LTF2, BioXcell).
-
bioRxiv - Immunology 2023Quote: ... 100 µg of CD4 and 100 µg of CD8 depleting antibodies were injected intraperitoneally in 100 µL sterile PBS per mouse 24 hours before challenge infection. 100 µg (Fig. 1) or 200 µg of the isotype control (Fig. 6) (clone LTF-2, Bio X Cell) were injected intraperitoneally in 100 µL of sterile PBS per mouse at the same time in control groups.
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Cell Biology 2020Quote: ... 8 and 11 anti-CTLA4 antibody (9H10; BioXCell) was administered interperitoneally at 200 μg per mouse ...
-
bioRxiv - Cancer Biology 2023Quote: ... injection of either a-PD-L1 antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone 10F.9G2, BioXcell) or isotype control antibody (200μg twice weekly for 2 weeks ...
-
bioRxiv - Immunology 2022Quote: ... 5 ug/ml Brefeldin A was supplemented 4 hrs before subsequent Fc blocking (2.4G2, BioXCell), surface antibody staining ...
-
bioRxiv - Immunology 2023Quote: ... or control IgG (n=8) (Syrian hamster IgG BioXCell), following the protocol depicted in Fig 4A.
-
bioRxiv - Neuroscience 2023Quote: ... was mixed with anti-mouse IL-2 (5 μg; Bioxcell, Clone JES6-1A12) in PBS at 37 °C for 30 min ...
-
bioRxiv - Immunology 2022Quote: ... and anti–mIFN-γ (8 μg/mL, Bio X Cell) (TH17 differentiation) ...
-
bioRxiv - Immunology 2021Quote: ... and anti–mIFN-γ (8 μg/mL, Bio X Cell) for TH17 differentiation ...
-
bioRxiv - Immunology 2021Quote: ... 1% GlutaMAX™ and 1% N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid [Gibco® HEPES]) and used as follow: TH1 conditions with anti–IL-4 (10 μg/mL, BioXCell, #BE0045) and IL-12 (10 ng/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2023Quote: ... with anti-IL-2 (S4B6-1, BioXcell, 100 µg), anti-CD154 (MR1 ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of 10μg/ml rIL-6 (R&D) and neutralizing antibodies to IL-2 (JES6-1A12 BioXcell, 5μg/ml and S4B6-1 BioXcell, 5μg/mL).
-
bioRxiv - Immunology 2020Quote: ... 2 and 5 post infection with 200 μg of the depleting antibody YTS 169.4 (BioXCell). Depletion of CD8 T cells was determined to be ~90% on day 7 post infection in the BM.
-
bioRxiv - Immunology 2023Quote: ... with the monoclonal antibody against human CD8 (clone OKT-8; BioXCell). The initial injection was 75 µg ...
-
bioRxiv - Immunology 2023Quote: ... and anti-CD28 (2 µg/ml, clone PV-1; BioXCell) or anti-NKG2D (10 µg/ml ...
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Cell Biology 2021Quote: ... (2) aged-matched control mice (n=7) that received weekly IP injections of the isotype control IgG2A antibody (2A3, Bio X Cell, Lebanon, NH) at 12 mg/kg for 8 weeks ...
-
bioRxiv - Immunology 2023Quote: ... and 8 post-infection with 200 ug of αCD8 (Clone 2.43 BioXcell) or control IgG antibody in 200 uL PBS (PMID ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Immunology 2023Quote: ... They were differentiated (9) for 2 days with plate bound anti-CD3 and anti-CD28 (2 μg mL-1 each; BioXcell) into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems ...
-
bioRxiv - Immunology 2023Quote: ... and anti-Ly-6C (clone: Monts 1, 2 mg/kg; BioXCell) were administered by intraperitoneal (i.p. ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2020Quote: ... each of anti-LFA-1 and anti-VLA-4 blocking antibodies (Bio X Cell) or control IgG ...
-
bioRxiv - Immunology 2024Quote: ... in the presence of soluble IL-2 and plate-bound anti-CD3 (5 μg/ml; 145-2C11; BioXcell)/anti-CD28 (2 μg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and 5 ug JES6-1 (BioXcell) intraperitoneally on days 2-4 post-infection in a total volume of 200 uL ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-murine PD-1 and anti-murine CTLA-4 were purchased from Bio X Cell (BE0146-clone RMP1-14 ...
-
bioRxiv - Immunology 2023Quote: ... Autocrine production of IL-2 was neutralized by the addition of an anti-IL2 antibody (InVivoMAb anti-mouse IL-2; clone JES6-1a12; BioXcell; Cat # BE0043-1) at 10 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...